Arvinas Inc

NASDAQ:ARVN   12:35:49 PM EDT
77.28
-0.02 (-0.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.68B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$6.91 Million
Adjusted EPS-$0.78
See more estimates
10-Day MA$77.20
50-Day MA$80.08
200-Day MA$42.16
See more pivots

Arvinas, Inc. Stock, NASDAQ:ARVN

5 Science Park, 395 Winchester Avenue, New Haven, Connecticut 06511
United States of America
Phone: +1.203.535.1456
Number of Employees: 133

Description

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110 and ARV-471. The company was founded in February 2013 and is headquartered in New Haven, CT.